The Metabolic Syndrome: Prevalence, Associated Risk Factors and Health Complications in Obese Subjects in Northern Morocco

  • Nadia HamjaneEmail author
  • Fatiha Benyahya
  • Mohcine Bennani Mechita
  • Naima Ghailani Nourouti
  • Amina Barakat
Conference paper
Part of the Advances in Intelligent Systems and Computing book series (AISC, volume 914)


The metabolic syndrome (MetS) is a major public-health problem; it is associated with increased risk of developing type 2 diabetes and cardiovascular diseases.

This study aimed to estimate the prevalence of MetS and associated risk factors as well as its complications in an obese population of north of Morocco.

This is a cross-sectional study that was undertaken on a population of 485 obese subjects, 339 women and 146 men. A structured questionnaire was used to collect data on demography, lifestyle, medical history and biological parameters.

The mean age of our patients was of 49 ± 11 years, the average of body mass index was of 34.2 ± 7 kg/m2, and the waist circumference average was of 106.9 ± 15 cm for the women and 104.5 ± 12 cm for the men. Obesity was of class I in 38% of the subjects, class II in 25%, class III in 13%, and 24% of the subjects had an overweight. The prevalence of MetS was 52.4%, higher in females than male subjects (59.24% vs 35.97%). The most commonly associated risk factors of MetS in our population were abdominal obesity plus hyperglycemia plus low HDL cholesterol. The complications found in our population were type2 diabetes and it complications in 42% of the cases and cardiovascular disease in 32%.

Our study showed that MetS was highly prevalent among obese patients. The most prevalent component of MetS in our population was abdominal obesity and hyperglycemia. Targeting obesity and sedentarity is the main solution for the prevention and treatment of the MetS.


Metabolic syndrome Obesity Complications 


  1. 1.
    Hauhouot-Attoungbre, M.L., Yayo, S.E., Ake-Edjeme, A., Yapi, H.F., Ahibo, H., Monnet, D.: Does metabolic syndrome exist in Ivory Coast? Le syndrome métabolique existe-t-il en Côte d’Ivoire? Immuno-analyse Biologie Spécialisée 23(6), 375–378 (2008)CrossRefGoogle Scholar
  2. 2.
    Scheen, A.J.: Management of the metabolic syndrome. Minerva Endocrinol. 29, 31–45 (2004)Google Scholar
  3. 3.
    Grundy, S.M.: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112(17), 2735–2752 (2005)CrossRefGoogle Scholar
  4. 4.
    Kim, M.H., Kim, M.K., Choi, B.Y., Shin, Y.J.: Prevalence of the metabolic syndrome and its association with Cardiovascular Disease in Korea. J. Korean Med. Sci. 19(2), 195–201 (2004)CrossRefGoogle Scholar
  5. 5.
    Qiao, Q.: Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. Diabetologia 49, 2837–2846 (2006)CrossRefGoogle Scholar
  6. 6.
    Park, Y.W., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, M.R., Heymsfield, S.B.: The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch. Intern. Med. 163, 427–436 (2003)CrossRefGoogle Scholar
  7. 7.
    Belfki, H., Ben Ali, S., Aounallah-Skhiri, H., et al.: Prevalence and determinants of the metabolic syndrome among Tunisian adults: results of the Transition and Health Impact in North Africa (TAHINA) project. Public Health Nutr. 16, 582–590 (2013)CrossRefGoogle Scholar
  8. 8.
    Houti, L., Hamani-Medjaoui, I., Lardjam-Hetraf, S.A., Ouhaibi-Djellouli, H., Chougrani, S., Goumidi, L., et al.: Prevalence of metabolic syndrome and its related risk factors in the City of Oran, Algeria: the ISOR Study. Ethn. Dis. 26, 99–106 (2016)CrossRefGoogle Scholar
  9. 9.
    El Brini, O., Akhouayri, O., Gamal, A., Mesfioui, A., Benazzouz, B.: Prevalence of metabolic syndrome and its components based on a harmonious definition among adults in Morocco. Diabetes Metab. Syndr. Obes. Targets Ther. 7, 341–346 (2014)Google Scholar
  10. 10.
    Morjane, I., Kefi, R., Charoute, H., Lakbakbi el Yaagoubi, F., Hechmi, M., Saile, R., et al.: Association study of HNF1A polymorphisms with metabolic syndrome in the Moroccan population. Diabetes Metab. Syndr. Clin. Res. Rev. 11, S853–S857 (2017)CrossRefGoogle Scholar
  11. 11.
    Lakbakbi El Yaagoubi, F., Charoute, H., Morjane, I., Sefri, H., Rouba, H., Ainahi, A., et al.: Association analysis of genetic variants with metabolic syndrome components in the Moroccan population. Curr. Res. Transl. Med. 65(3), 121–125 (2017)CrossRefGoogle Scholar
  12. 12.
    Ajjemami, M., Ouatou, S., Charoute, H., Fakiri, M., Rhaissi, H., Benrahma, H., et al.: Haplotype analysis of the Apolipoprotein A5 gene in Moroccan patients with the metabolic syndrome. J. Diabetes Metab. Disord. 14, 29 (2015)CrossRefGoogle Scholar
  13. 13.
    Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285, 2486–2497 (2001)CrossRefGoogle Scholar
  14. 14.
    Grundy, S.M., Cleeman, J.I., Daniels, S.R., et al.: Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112(17), 2735–2752 (2005)CrossRefGoogle Scholar
  15. 15.
    Barrios, V., Escobar, C., Calderón, A., Llisterri, J.L., Alegría, E., Muñiz, J., et al.: Prevalence of the metabolic syndrome in patients with hypertension treated in general practice in Spain: an assessment of blood pressure and low-density lipoprotein cholesterol control and accuracy of diagnosis. J. Cardiometab. Syndr. 2(1), 9–15 (2007)CrossRefGoogle Scholar
  16. 16.
    Dang Thi Mai, K., Tran Van, N.: Study of the prevalence of metabolic syndrome in patients with sleep apnea syndrome. Fran Viet Pneu 04(10), 36–42 (2013)Google Scholar
  17. 17.
    Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., et al.: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24, 683–689 (2001)CrossRefGoogle Scholar
  18. 18.
    Poulsen, P., Vaag, A., Kyvik, K., Beck-Nielsen, H.: Genetic versus environmental aetiology of the metabolic syndrome among male and female twins. Diabetologia 44, 537–543 (2001)CrossRefGoogle Scholar
  19. 19.
    Nolan, P.B., Carrick-Ranson, G., Stinear, J.W., Reading, S.A., Dalleck, L.C.: Prevalence of metabolic syndrome and metabolic syndrome components in young adults: a pooled analysis. Prev. Med. Rep. 7, 211–215 (2017)CrossRefGoogle Scholar
  20. 20.
    O’Neill, S., O’Driscoll, L.: Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies: metabolic syndrome. Obes. Rev. 16(1), 1–12 (2015)CrossRefGoogle Scholar
  21. 21.
    Prasad, D.S., Kabir, Z., Dash, A.K., Das, B.C.: Prevalence and risk factors for metabolic syndrome in Asian Indians: a community study from urban Eastern India. J. Cardiovasc. Dis. Res. 3, 204–211 (2012)CrossRefGoogle Scholar
  22. 22.
    Shahbazian, H., Latifi, S.M., Jalali, M.T., Shahbazian, H., Amani, R., Nikhoo, A., et al.: Metabolic syndrome and its correlated factors in an urban population in South West of Iran. J. Diabetes Metab. Disord. 12(1), 11 (2013)CrossRefGoogle Scholar
  23. 23.
    Pascot, A., Després, J.P., Lemieux, I., Alméras, N., Bergeron, J., Nadeau, A., et al.: Deterioration of the metabolic risk profile in women. Respective contributions of impaired glucose tolerance and visceral fat accumulation. Diabetes Care 24(5), 902–908 (2001)CrossRefGoogle Scholar
  24. 24.
    Despres, J.-P., Lemieux, I., Bergeron, J., Pibarot, P., Mathieu, P., Larose, E., et al.: Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler. Thromb. Vasc. Biol. 28(6), 1039–1049 (2008)CrossRefGoogle Scholar
  25. 25.
    Roberts, C.K., Hevener, A.L., Barnard, R.J.: Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. In: Terjung, R. (ed.) Comprehensive Physiology, vol. 3(1), pp. 1–58 (2013)Google Scholar
  26. 26.
    Soysal, A., Demiral, Y., Soysal, D., Uçku, R., Köseoğlu, M., Aksakoğlu, G.: The prevalence of metabolic syndrome among young adults in Izmir, Turkey. Anadolu Kardiyol Derg. 5(3), 196–201 (2005)Google Scholar
  27. 27.
    Yeboah, K., Dodam, K.K., Affrim, P.K., Adu-Gyamfi, L., Bado, A.R., Owusu Mensah, R.N.A., et al.: Metabolic syndrome and parental history of cardiovascular disease in young adults in urban Ghana. BMC Public Health 18(1), 96 (2017)CrossRefGoogle Scholar
  28. 28.
    Ben Romdhane, H., Ben Ali, S., Skhiri, H., Traissac, P., Bougatef, S., Maire, B., et al.: Hypertension among Tunisian adults: results of the TAHINA project. Hypertens. Res. 35(3), 341–347 (2012)CrossRefGoogle Scholar
  29. 29.
    Lorenzo, C., Okoloise, M., Williams, K., et al.: The metabolic syndrome as predictor of type 2 diabetes. Diabetes Care 26, 3153–3159 (2003)CrossRefGoogle Scholar
  30. 30.
    Stern, M.P., Williams, K., Gonzalez-Villalpando, C., Hunt, K.J., Haffner, S.M.: Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 27, 2676–2681 (2004)CrossRefGoogle Scholar
  31. 31.
    Mottillo, S., Filion, K.B., Genest, J., Joseph, L., Pilote, L., Poirier, P., Rinfret, S., Schiffrin, E.L., Eisenberg, M.J.: The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis. J. Am. Coll. Cardiol. 56(14), 1113–1132 (2010)CrossRefGoogle Scholar
  32. 32.
    Dekker, J.M., Girman, C., Rhodes, T., Nijpels, G., Stehouwer, C.D.A., Bouter, L.M., Heine, R.J.: Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn study. Circulation 112(5), 666–673 (2005)CrossRefGoogle Scholar
  33. 33.
    Ford, E.S.: The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 173, 309–314 (2004)CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Laboratory of Biomedical Genomics and OncogeneticsAbdelmalek Essaadi UniversityTangierMorocco
  2. 2.Institute PasteurTangierMorocco

Personalised recommendations